Literature DB >> 25759528

Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.

Hyun Joo Shin1, Eun Young Chang1, Hye Sun Lee1, Jung Hwa Hong1, Gyuri Park1, Hyun Gi Kim1, Myung-Joon Kim1, Mi-Jung Lee1.   

Abstract

AIM: To investigate perfusion change in contrast-enhanced ultrasonography (CEUS) to evaluate liver fibrosis based on biliary obstruction using an animal model.
METHODS: New Zealand white rabbits (3-4 kg) underwent bile duct ligation to form a biliary obstruction model. We performed liver CEUS and laboratory tests on the day before the operation (day 0) and every 7 postoperative days until the rabbits were sacrificed. After CEUS, signal intensity of liver parenchyma with a time-intensity curve was analyzed. Perfusion parameters were automatically calculated from region-of-interests, including peak signal intensity, mean transit time, area under the curve and time to peak. Histological grades of liver fibrosis were assessed according to the Metavir score system immediately after sacrifice. Generalized estimating equations were used to analyze the association between liver fibrosis grades and perfusion parameters for statistical analysis. The perfusion parameters were measured on the last day and the difference between day 0 and the last day were evaluated.
RESULTS: From the nine rabbits, histological grades of liver fibrosis were grade 1 in one rabbit, grade 2 and 3 in three rabbits each, and grade 4 in two rabbits. Among the four CEUS parameters, only the peak signal intensity measured on the last day demonstrated a significant association with liver fibrosis grades (OR = 1.392, 95%CI: 1.114-1.741, P = 0.004). The difference in peak signal intensity between day 0 and the last day also demonstrated an association with liver fibrosis (OR = 1.191, 95%CI: 0.999-1.419, P = 0.051). The other parameters tested, including mean transit time, area under the curve, and time to peak, showed no significant correlation with liver fibrosis grades.
CONCLUSION: This animal study demonstrates that CEUS can be used to evaluate liver fibrosis from biliary obstruction using peak signal intensity as a parameter.

Entities:  

Keywords:  Animals; Bile ducts; Contrast enhanced ultrasound; Ligation; Liver cirrhosis; Rabbits; Ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 25759528      PMCID: PMC4351210          DOI: 10.3748/wjg.v21.i9.2614

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Biliary atresia: color doppler US findings in neonates and infants.

Authors:  Mu Sook Lee; Myung-Joon Kim; Mi-Jung Lee; Choon Sik Yoon; Seok Joo Han; Jung-Tak Oh; Young Nyun Park
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

2.  Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia.

Authors:  Na-Young Shin; Myung-Joon Kim; Mi-Jung Lee; Seok Joo Han; Hong Koh; Ran Namgung; Young Nyun Park
Journal:  J Ultrasound Med       Date:  2014-05       Impact factor: 2.153

3.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Authors:  F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott
Journal:  Ultraschall Med       Date:  2011-08-26       Impact factor: 6.548

4.  Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases.

Authors:  Francesco Ridolfi; Teresa Abbattista; Paolo Busilacchi; Eugenio Brunelli
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

5.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

Authors:  C Aubé; F Oberti; N Korali; M A Namour; D Loisel; J Y Tanguy; E Valsesia; C Pilette; M C Rousselet; P Bedossa; H Rifflet; M Y Maïga; D Penneau-Fontbonne; C Caron; P Calès
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

6.  Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.

Authors:  G A Ramm; V G Nair; K R Bridle; R W Shepherd; D H Crawford
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Dynamic Vascular Pattern (DVP), a quantification tool for contrast enhanced ultrasound.

Authors:  X W Cui; A Ignee; M Jedrzejczyk; C F Dietrich
Journal:  Z Gastroenterol       Date:  2013-05-16       Impact factor: 2.000

8.  Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C.

Authors:  F Ridolfi; T Abbattista; F Marini; A Vedovelli; P Quagliarini; P Busilacchi; E Brunelli
Journal:  Dig Liver Dis       Date:  2007-07-31       Impact factor: 4.088

Review 9.  Biliary atresia.

Authors:  Jane L Hartley; Mark Davenport; Deirdre A Kelly
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

10.  Grey scale enhancement by a new self-made contrast agent in early cirrhotic stage of rabbit liver.

Authors:  Li Zhang; Yun-You Duan; Ji-Kai Yin; Ji-Hong Cui; Yong Zhang; Tie-Sheng Cao
Journal:  BMC Gastroenterol       Date:  2007-08-08       Impact factor: 3.067

View more
  2 in total

1.  Repeatability of the "flash-replenishment" method in contrast-enhanced ultrasound for the quantitative assessment of hepatic microvascular perfusion.

Authors:  Fang Xie; Wen-Bo Wan; Xiang Fei; Ming-Bo Zhang; Yan Zhang; Hong-Wei Wang; Jie Tang; Wen-Bo Tang; Yu-Kun Luo
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

Review 2.  Quantitative Imaging in Pediatric Hepatobiliary Disease.

Authors:  Haesung Yoon; Hyun Joo Shin; Myung Joon Kim; Mi Jung Lee
Journal:  Korean J Radiol       Date:  2019-09       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.